IL163750A0 - Process for preparing (2-(4-(6-fluorobenzo(D)isoxazol-3-yl)-piperidin-1yl)-ethyl)-2- methyl-6,7,8,9-tetrahydro-4H-pyrido-(1, - Google Patents

Process for preparing (2-(4-(6-fluorobenzo(D)isoxazol-3-yl)-piperidin-1yl)-ethyl)-2- methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,

Info

Publication number
IL163750A0
IL163750A0 IL16375003A IL16375003A IL163750A0 IL 163750 A0 IL163750 A0 IL 163750A0 IL 16375003 A IL16375003 A IL 16375003A IL 16375003 A IL16375003 A IL 16375003A IL 163750 A0 IL163750 A0 IL 163750A0
Authority
IL
Israel
Prior art keywords
fluorobenzo
isoxazol
pyrido
piperidin
tetrahydro
Prior art date
Application number
IL16375003A
Other languages
English (en)
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of IL163750A0 publication Critical patent/IL163750A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
IL16375003A 2002-03-05 2003-03-03 Process for preparing (2-(4-(6-fluorobenzo(D)isoxazol-3-yl)-piperidin-1yl)-ethyl)-2- methyl-6,7,8,9-tetrahydro-4H-pyrido-(1, IL163750A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200531A ES2197801B1 (es) 2002-03-05 2002-03-05 Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
PCT/EP2003/002157 WO2003074522A1 (en) 2002-03-05 2003-03-03 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one

Publications (1)

Publication Number Publication Date
IL163750A0 true IL163750A0 (en) 2005-12-18

Family

ID=27772022

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16375003A IL163750A0 (en) 2002-03-05 2003-03-03 Process for preparing (2-(4-(6-fluorobenzo(D)isoxazol-3-yl)-piperidin-1yl)-ethyl)-2- methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,

Country Status (22)

Country Link
US (1) US7205405B2 (xx)
EP (1) EP1480978A1 (xx)
JP (1) JP2005525366A (xx)
KR (1) KR100680003B1 (xx)
CN (1) CN1315826C (xx)
AU (1) AU2003219010A1 (xx)
BR (1) BR0308139A (xx)
CA (1) CA2474811A1 (xx)
CO (1) CO5611140A2 (xx)
CR (1) CR7462A (xx)
ES (1) ES2197801B1 (xx)
IL (1) IL163750A0 (xx)
MA (1) MA26353A1 (xx)
MX (1) MXPA04008289A (xx)
NO (1) NO20043447L (xx)
NZ (1) NZ534463A (xx)
PL (1) PL370502A1 (xx)
RU (1) RU2272037C9 (xx)
TN (1) TNSN04139A1 (xx)
UA (1) UA80114C2 (xx)
WO (1) WO2003074522A1 (xx)
ZA (1) ZA200405939B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0214716B8 (pt) * 2001-12-05 2021-05-25 Teva Womens Health Inc kit, preparos, e uso de estrogênio e progestina na fabricação de um medicamento para uso na prevenção de gravidez
KR20040025224A (ko) * 2002-09-18 2004-03-24 주식회사 대웅 2-(2-메틸-4-옥소-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-3-일)아세트알데히드 및 그 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
CA2000786C (en) * 1988-11-07 1999-01-26 Cornelus G. M. Janssen 3-piperidinyl-1,2-benzisoxazoles
GB9008850D0 (en) * 1990-04-19 1990-06-13 Janssen Pharmaceutica Nv Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
CZ295402B6 (cs) * 2000-05-05 2005-08-17 Rpg Life Sciences Limited Způsob přípravy antipsychotického 3-[2-[4-(6-fluor-1,2-benzizoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2,-a]pyrimidin-4-onu

Also Published As

Publication number Publication date
MXPA04008289A (es) 2004-11-26
MA26353A1 (fr) 2004-10-01
NZ534463A (en) 2006-02-24
JP2005525366A (ja) 2005-08-25
KR100680003B1 (ko) 2007-02-08
UA80114C2 (en) 2007-08-27
ES2197801A1 (es) 2004-01-01
ES2197801B1 (es) 2005-03-16
CA2474811A1 (en) 2003-09-12
WO2003074522A1 (en) 2003-09-12
PL370502A1 (en) 2005-05-30
KR20040091679A (ko) 2004-10-28
CR7462A (es) 2005-02-10
ZA200405939B (en) 2006-06-28
RU2272037C1 (ru) 2006-03-20
NO20043447L (no) 2004-08-18
CN1315826C (zh) 2007-05-16
BR0308139A (pt) 2005-01-04
CN1639163A (zh) 2005-07-13
TNSN04139A1 (en) 2007-03-12
US7205405B2 (en) 2007-04-17
CO5611140A2 (es) 2006-02-28
RU2272037C9 (ru) 2006-06-20
US20050143395A1 (en) 2005-06-30
AU2003219010A1 (en) 2003-09-16
EP1480978A1 (en) 2004-12-01

Similar Documents

Publication Publication Date Title
EP1625123A4 (en) 3- (2-AMINO-1-AZACYCLYL) -5-ARYL-1,2,4-OXADIAZOLE AS S1P RECEPTOR AGONISTS
IL162721A0 (en) 2-(Pyridin-2-ylamino)-pyridoÄ2,3-dÜpyrimidin-7-ones
EP1697333A4 (en) 3,4-DISUSBSTITUTED PROPANOIC CARBOXYLATES AS S1P RECEPTOR AGONISTS (EDG)
IL183568A (en) Process for making 7,8-dihydro-5 h-patridine-6-onh
IL195011A0 (en) Process for preparing piperidine derivatives
EP1549640A4 (en) 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) AZETIDINE-3-CARBOXYLATE AND 1 - ((5-ARYL-1,2,4-OXADIAZOL-3-YL) BENZYL) PYRROLIDIN-3-CARBOXYLATE AS EDG RECEPTOR AGONISTS
ZA200702382B (en) Processes for the preparation of substituted 2-(2,6-dioxoplperidin-3-yl)-1-oxoisoindolines
HK1078568A1 (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
ITMI20010029U1 (it) Apparato di riscaldamento per macchina lavastoviglie
AP1882A (en) Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-Benzothiazole.
HK1078863A1 (en) Process for preparing (s)-pantoprazole
PL1829868T3 (pl) Sposób wytwarzania soli (4,5-dihydroizoksazol-3-ilo)tiokarboksyamidyny
TWI347947B (en) Process for preparing [4-(1,3,4-oxadiazol-2-yl)phenyl] boronic acid and use thereof
IL163750A0 (en) Process for preparing (2-(4-(6-fluorobenzo(D)isoxazol-3-yl)-piperidin-1yl)-ethyl)-2- methyl-6,7,8,9-tetrahydro-4H-pyrido-(1,
PT1613594E (pt) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inibidores da recaptação da serotonina
EP1550772A4 (en) ROTATING DEVICE FOR CONSTRUCTION MACHINE
HRP20040557A2 (en) Process for preparing 2-(substituted phenyl)-2-hydroxy carbamates
AP2001002231A0 (en) Process for preparing 2-(4-pyridyl) amino-6- dialkoxyphenyl-pyrido¬2,3-d¾ pyrimidin-7-0 nes
IL175068A0 (en) New process for preparing an optically pure-2-morphinol derivative
HK1152699A1 (en) Method for preparing trans-4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2- trimethylpiperazine and the salts thereof and the intermediates used therein
AU2003259866A8 (en) Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
EP1806344A4 (en) OPTICALLY ACTIVE 4,4-DISUBSTITUTED OXAZOLIDINE DERIVATIVE AND SYNTHESIS METHOD OF SAID DERIVATIVE
HUP0204342A3 (en) Process for producing 3-[2-(3,4-dimethoxybenzoyl)-4,5-dimethoxyphenyl]-pentan-2-one
IL163964A (en) Method for producing 2,2-dichloro or dibromo-phenyl alkyl acetates
GB0522075D0 (en) Process for preparing almodipline mesylate monohydrate